Zacks Rating on AmerisourceBergen Corporation (Holding Co) (ABC)

AmerisourceBergen Corporation (Holding Co) (ABC) : 11 analysts are covering AmerisourceBergen Corporation (Holding Co) (ABC) and their average rating on the stock is 2.82, which is read as a Hold. 1 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 10 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

AmerisourceBergen Corporation (Holding Co) (ABC) : 10 investment research analysts covering AmerisourceBergen Corporation (Holding Co) (ABC) have an average price target of $89 for the near short term. The highest target price given by the Brokerage Firm to the stock is $96 and the lowest target is $77 for the short term. Analysts expect the variance to be within $5.27 of the average price.


AmerisourceBergen Corporation has dropped 0.14% in the last five trading days, however, the shares have posted positive gains of 4.59% in the last 4 weeks. AmerisourceBergen Corporation is up 20.17% in the last 3-month period. Year-to-Date the stock performance stands at -13.14%. AmerisourceBergen Corporation (Holding Co) (NYSE:ABC): stock turned positive on Tuesday. Though the stock opened at $89.14, the bulls momentum made the stock top out at $89.23 level for the day. The stock recorded a low of $88.83 and closed the trading day at $88.99, in the green by 0.27%. The total traded volume for the day was 638,202. The stock had closed at $88.75 in the previous days trading.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.